Skip to content

APOTHEEK DECLOEDT: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK DECLOEDT

BE 0462.848.168
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€41,934
2024 · €50,092-€8,158
Equity
€432,804
2024 · €406,869+€25,934
Cash
€250,239
2024 · €222,249+€27,991
Balance sheet total
€512,604
2024 · €474,087+€38,517

Largest movements

2024 to 2025
Assets
  • Cash +€27,991

    up €27,991 (+12.6%), from €222,249 to €250,239

    mainly Net result for the year (+€41,934) and Stocks and contracts (+€16,437)

  • Tangible fixed assets +€21,072

    up €21,072 (+37.4%), from €56,344 to €77,416

    of which Land and buildings: +€22,836

  • Stocks and contracts -€16,437

    down €16,437 (-10.2%), from €161,283 to €144,846

Equity and liabilities
  • Reserves +€25,934

    up €25,934 (+12.8%), from €202,529 to €228,464

    of which Distributable reserves: +€25,934

  • Trade debts +€9,332

    up €9,332 (+36.1%), from €25,870 to €35,202

Income statement
  • Gross operating margin -€9,346

    down €9,346 (-10.5%), from €89,103 to €79,757

  • Taxes -€4,117

    down €4,117 (-18.4%), from €22,433 to €18,315

  • Staff costs +€1,914

    new in 2025: €1,914

  • Depreciation +€1,326

    up €1,326 (+9.5%), from €13,909 to €15,235

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €50,092
Gross operating margin -€9,346
Staff costs -€1,914
Depreciation -€1,326
Other operating charges -€98
Financial income +€691
Financial charges -€282
Taxes +€4,117
Result 2025 €41,934
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€80,297
Investment -€36,306
Financing -€16,000
Cash 2024 €222,249
Net result for the year +€41,934
Depreciation +€15,235
Stocks and contracts +€16,437
Receivables within one year -€3,650
Deferred charges and accrued income -€2,240
Trade debts +€9,332
Tax, wage and social debts -€287
Other debts +€3,520
Accrued charges and deferred income +€17
Investment in fixed assets (net) -€36,306
Contributions, distributions and other -€16,000
Cash 2025 €250,239
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €474,087 €512,604 +€38,517 +8.1%
Fixed assets 21/28 €56,344 €77,416 +€21,072 +37.4%
Intangible fixed assets 21 €0 - =
Tangible fixed assets 22/27 €56,344 €77,416 +€21,072 +37.4%
Land and buildings 22 €49,898 €72,734 +€22,836 +45.8%
Furniture and vehicles 24 €6,446 €4,682 -€1,764 -27.4%
Current assets 29/58 €417,743 €435,188 +€17,445 +4.2%
Stocks and contracts in progress 3 €161,283 €144,846 -€16,437 -10.2%
Stocks 30/36 €161,283 €144,846 -€16,437 -10.2%
Amounts receivable within one year 40/41 €11,039 €14,689 +€3,650 +33.1%
Trade receivables 40 €11,039 €13,009 +€1,970 +17.8%
Other amounts receivable 41 €0 €1,680 +€1,680
Cash at bank and in hand 54/58 €222,249 €250,239 +€27,991 +12.6%
Deferred charges and accrued income 490/1 €23,173 €25,414 +€2,240 +9.7%
Total equity and liabilities 10/49 €474,087 €512,604 +€38,517 +8.1%
Equity 10/15 €406,869 €432,804 +€25,934 +6.4%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €202,529 €228,464 +€25,934 +12.8%
Non-distributable reserves 130/1 €0 - =
Reserves not available under the articles 1311 €0 - =
Distributable reserves 133 €202,529 €228,464 +€25,934 +12.8%
Profit (loss) carried forward 14 €191,940 €191,940 = 0.0%
Amounts payable 17/49 €67,218 €79,800 +€12,582 +18.7%
Amounts payable within one year 42/48 €64,768 €77,334 +€12,566 +19.4%
Trade debts 44 €25,870 €35,202 +€9,332 +36.1%
Suppliers 440/4 €25,870 €35,202 +€9,332 +36.1%
Taxes, remuneration and social security 45 €24,785 €24,499 -€287 -1.2%
Taxes 450/3 €21,365 €16,399 -€4,967 -23.2%
Remuneration and social security 454/9 €3,420 €8,100 +€4,680 +137%
Other amounts payable 47/48 €14,112 €17,632 +€3,520 +24.9%
Accrued charges and deferred income 492/3 €2,450 €2,467 +€17 +0.7%
Remuneration, social security and pensions 62 - €1,914 +€1,914
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €13,909 €15,235 +€1,326 +9.5%
Other operating charges 640/8 €3,133 €3,231 +€98 +3.1%
Gross operating margin 9900 €89,103 €79,757 -€9,346 -10.5%
Operating profit (loss) 9901 €72,061 €59,378 -€12,684 -17.6%
Financial income 75/76B €633 €1,323 +€691 +109%
Recurring financial income 75 €633 €1,323 +€691 +109%
Financial charges 65/66B €169 €451 +€282 +167%
Recurring financial charges 65 €169 €451 +€282 +167%
Profit (loss) for the period before taxes 9903 €72,525 €60,250 -€12,275 -16.9%
Income taxes 67/77 €22,433 €18,315 -€4,117 -18.4%
Profit (loss) for the period 9904 €50,092 €41,934 -€8,158 -16.3%
Profit (loss) for the period to be appropriated 9905 €50,092 €41,934 -€8,158 -16.3%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.